Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Prevention of HEMOrhagic Risk in Upper MYOmeCTomy by Use of Misoprostol. — Stella

Home/Myoma;Uterus/Prevention of HEMOrhagic Risk in Upper MYOmeCTomy by Use of Misoprostol.

View on ClinicalTrials.gov

Recruiting

Back to Myoma;Uterus trials

Prevention of HEMOrhagic Risk in Upper MYOmeCTomy by Use of Misoprostol.

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

France

CHU Clermont-Ferrand, Clermont-Ferrand, Clermont-Ferrand

Key details

Sponsor

University Hospital, Clermont-Ferrand

Enrollment target

~80 participants

Started

March 2025

Primary completion

April 2027

Age range

18 Years – 43 Years

Sex

Female only

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.